ASX: ACW - Xanamem Clinical Development & Investor Update.

Tuesday, July 2, 2019 10:00 PM +00:00

ASX: ACW - Xanamem Clinical Development & Inv...0:0010:09
LIVEQuality1  AudioSubtitleDownloadSpeed1  
ACTINOGEN LIMITED
Bill Ketelbey

Actinogen Medical (ASX: ACW) is pleased to provide an update on the progress the Company is making with the ongoing clinical development program for Xanamem™. This update should be read in conjunction with the latest investor presentation.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 15 Jul

    00:00

    Senior-Leadership Succession Podcast July 12, 2019

    ACCENTURE PLC
  • 15 Jul

    00:00

    Ford - Volkswagen AG Providing Update on Global Collaboration July 12, 2019

    FORD MOTOR COMPANY
  • 15 Jul

    00:00

    Proposed sale of 60% of Kantar 12 July 2019

    WPP
  • 15 Jul

    01:00

    Osprey Medical Quarterly Results Investor Call

    OSPREY MEDICAL INC
  • 15 Jul

    01:30

    Investor Call June Quarter 2019

    MOUNT GIBSON IRON LIMITED